New York, New York (PRWEB) June 24, 2014
DePuy Pinnacle hip lawsuits (http://www.depuypinnacle-lawsuit.com/) involving a metal-on-metal version of the hip replacement system continue to move forward in a multidistrict litigation underway in U.S. District Court, Northern District of Texas, Bernstein Liebhard LLP reports. According to a Motion filed on June 17th, two plaintiffs with claims pending in the proceeding have asked the Court that witnesses be allowed to give live trial testimony via satellite from outside of Texas, due to concerns that certain witnesses may not be produced by the Defense. Among other things, the Motion points out that while the Defense has committed to producing a number of witnesses sought by Plaintiffs, commitments have not been made for all. The Plaintiffs also assert that the satellite transmission would be appropriate, as they are not from Texas and did not choose the Northern District of Texas as the forum for their DePuy Pinnacle lawsuits. (In re: DePuy Orthopaedics Inc. Pinnacle Hip Implant Product Liability Litigation, MDL No. 2244)
“Our Firm is representing numerous clients who have filed Pinnacle hip lawsuits in this litigation. We will be monitoring this matter closely,” says Bernstein Liebhard LLP, a nationwide law firm representing victims of dangerous drugs and medical devices. The Firm continues to offer free case reviews to individuals who may have been injured by the all-metal DePuy Pinnacle hip implant.
DePuy Pinnacle Hip Lawsuits
Court documents indicate that more than 6,200 Pinnacle hip lawsuits have been filed in the Northern District of Texas on behalf of individuals who were allegedly injured by a version of the hip replacement system that utilizes the Ultamet liner. Plaintiffs allege that the metal-on-metal design created by this configuration is prone to shedding dangerous amounts of toxic metal debris into recipients’ tissue and blood stream, resulting in chronic pain, metallosis (metal ion poisoning), pseudotumor formation and premature device failure. Johnson & Johnson and its DePuy Orthopaedics unit are accused of failing to adequately test the implant or provide doctors and patients with appropriate warnings about its risk.
Jeffrey S. Grand, a partner with Bernstein Liebhard LLP, is serving on the Plaintiffs’ Steering Committee in the federal Pinnacle litigation. According to court documents, the first federal trial of a DePuy Pinnacle hip lawsuit is expected to begin in September 2014.
In May 2013, Johnson & Johnson and DePuy Orthopaedics announced that they would cease the sale of metal-on-metal hip implants, including the device involved in Pinnacle hip lawsuits. The companies’ action followed an alert issued by the U.S. Food & Drug Administration (FDA) in January 2013, which warned that metal-on-metal hips were more likely to fail early than those made of other materials. The agency also revealed that it was considering new rules that would subject the all-metal hips to greater regulatory oversight.*
Individuals who were allegedly harmed by the metal-on-metal DePuy Pinnacle hip may be entitled to compensation for their medical bills, lost wages, pain and suffering, and other damages. To learn more about filing a Pinnacle hip lawsuit, please visit Bernstein Liebhard LLP’s website. For a free case evaluation, please call 800-511-5092 today.
*bloomberg.com/news/2013-05-16/j-j-will-stop-sales-of-metal-on-metal-hip-replacements.html, Bloomberg.com, May 17, 2013
About Bernstein Liebhard LLP
Bernstein Liebhard LLP is a New York-based law firm exclusively representing injured persons in complex individual and class action lawsuits nationwide since 1993. As a national law firm, Bernstein Liebhard LLP possesses all of the legal and financial resources required to successfully challenge billion dollar pharmaceutical and medical device companies. As a result, our attorneys and legal staff have been able to recover more than $3 billion on behalf of our clients. The Firm has been named by The National Law Journal to the Plaintiffs’ Hot List, recognizing the top plaintiffs firms in the country, for the past 12 consecutive years. Bernstein Liebhard LLP is the only firm in the country to be named to this prestigious list every year since it was first published in 2003.
Bernstein Liebhard LLP represents the victims of defective drugs and medical devices on a contingency-fee basis, and our clients are never expected to pay attorneys fees unless their case results in a successful recovery on their behalf. New York State’s contingency fee cap rules generally limit those fees to 33 1/3% of the total recovery. As a result, the Firm’s fees can be significantly lower than those assessed by attorneys in other states, which depending on the law may amount to as much as 40% or more of a plaintiff’s recovery.
Bernstein Liebhard LLP
10 East 40th Street
New York, New York 10016
ATTORNEY ADVERTISING. © 2014 Bernstein Liebhard LLP. The law firm responsible for this advertisement is Bernstein Liebhard LLP, 10 East 40th Street, New York, New York 10016, 800-511-5092. Prior results do not guarantee or predict a similar outcome with respect to any future matter.
Felecia L. Stern, Esq.
Bernstein Liebhard LLP